APA
Toledo-Sherman L., Breccia P., Cachope R., Bate J. R., Angulo-Herrera I., Wishart G., Matthews K. L., Martin S. L., Cox H. C., McAllister G., Penrose S. D., Vater H., Esmieu W., Van de Poël A., Van de Bospoort R., Strijbosch A., Lamers M., Leonard P., Jarvis R. E., Blackaby W., Barnes K., Eznarriaga M., Dowler S., Smith G. D., Fischer D. F., Lazari O., Yates D., Rose M., Jang S., Muñoz-Sanjuan I. & Dominguez C. (20200303). Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models. : Journal of medicinal chemistry.
Chicago
Toledo-Sherman Leticia, Breccia Perla, Cachope Roger, Bate Jennifer R, Angulo-Herrera Ivan, Wishart Grant, Matthews Kim L, Martin Sarah L, Cox Helen C, McAllister George, Penrose Stephen D, Vater Huw, Esmieu William, Van de Poël Amanda, Van de Bospoort Rhea, Strijbosch Annelieke, Lamers Marieke, Leonard Philip, Jarvis Rebecca E, Blackaby Wesley, Barnes Karen, Eznarriaga Maria, Dowler Simon, Smith Graham D, Fischer David F, Lazari Ovadia, Yates Dawn, Rose Mark, Jang Sung-Wook, Muñoz-Sanjuan Ignacio and Dominguez Celia. 20200303. Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models. : Journal of medicinal chemistry.
Harvard
Toledo-Sherman L., Breccia P., Cachope R., Bate J. R., Angulo-Herrera I., Wishart G., Matthews K. L., Martin S. L., Cox H. C., McAllister G., Penrose S. D., Vater H., Esmieu W., Van de Poël A., Van de Bospoort R., Strijbosch A., Lamers M., Leonard P., Jarvis R. E., Blackaby W., Barnes K., Eznarriaga M., Dowler S., Smith G. D., Fischer D. F., Lazari O., Yates D., Rose M., Jang S., Muñoz-Sanjuan I. and Dominguez C. (20200303). Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models. : Journal of medicinal chemistry.
MLA
Toledo-Sherman Leticia, Breccia Perla, Cachope Roger, Bate Jennifer R, Angulo-Herrera Ivan, Wishart Grant, Matthews Kim L, Martin Sarah L, Cox Helen C, McAllister George, Penrose Stephen D, Vater Huw, Esmieu William, Van de Poël Amanda, Van de Bospoort Rhea, Strijbosch Annelieke, Lamers Marieke, Leonard Philip, Jarvis Rebecca E, Blackaby Wesley, Barnes Karen, Eznarriaga Maria, Dowler Simon, Smith Graham D, Fischer David F, Lazari Ovadia, Yates Dawn, Rose Mark, Jang Sung-Wook, Muñoz-Sanjuan Ignacio and Dominguez Celia. Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models. : Journal of medicinal chemistry. 20200303.